The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124398655 12439865 5 F 20160414 20160606 20160722 EXP PHHY2016NL073198 NOVARTIS DOS SANTOS CO, ZIJLSTRA JG, PORTE RJ, KAMPINGA GA, VAN DIEPENINGEN AD, SINHA B ET AL.. EMERGING PAN-RESISTANCE IN TRICHOSPORON SPECIES: A CASE REPORT.. BMC INFECTIOUS DISEASES. 2016;16(148):1-4 48.00 YR M Y 0.00000 20160722 OT NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124398655 12439865 1 PS BASILIXIMAB BASILIXIMAB 1 Unknown 20 MG, UNK 103764 20 MG
124398655 12439865 2 SS BASILIXIMAB BASILIXIMAB 1 103764
124398655 12439865 3 SS HYDROCORTISONE. HYDROCORTISONE 1 Intravenous (not otherwise specified) 4 MG, QH 0 4 MG /hr
124398655 12439865 4 SS HYDROCORTISONE. HYDROCORTISONE 1 0
124398655 12439865 5 SS CEFTRIAXONE. CEFTRIAXONE 1 Intravenous (not otherwise specified) 2000 MG, QD 0 2000 MG QD
124398655 12439865 6 SS PIPERACILLIN, TAZOBACTAM PIPERACILLIN SODIUMTAZOBACTAM SODIUM 1 Intravenous (not otherwise specified) 4000 MG, TID 0 4000 MG TID
124398655 12439865 7 SS PIPERACILLIN, TAZOBACTAM PIPERACILLIN SODIUMTAZOBACTAM SODIUM 1 Intravenous (not otherwise specified) 4000 MG, TID 0 5000 MG TID
124398655 12439865 8 SS FLUCONAZOLE. FLUCONAZOLE 1 Intravenous (not otherwise specified) 100 MG, QD 0 100 MG QD
124398655 12439865 9 SS MEROPENEM. MEROPENEM 1 Intravenous (not otherwise specified) 1000 MG, BID 0 1000 MG BID
124398655 12439865 10 SS VORICONAZOLE. VORICONAZOLE 1 Intravenous (not otherwise specified) 200 MG, BID 0 200 MG BID
124398655 12439865 11 SS AMPHOTERICIN B. AMPHOTERICIN B 1 Intravenous (not otherwise specified) 0.3 MG/KG, QD 0 .3 MG/KG QD
124398655 12439865 12 C POLYMYXIN B. POLYMYXIN B 1 Unknown 2 %, UNK 0 2 PCT
124398655 12439865 13 C TOBRAMYCIN. TOBRAMYCIN 1 Unknown 2 %, UNK 0 2 PCT
124398655 12439865 14 C AMPHOTERICIN B, LIPOSOME AMPHOTERICIN B 1 Intravenous (not otherwise specified) 5 MG/KG, QD 0 5 MG/KG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124398655 12439865 1 Liver transplant
124398655 12439865 2 Immunosuppressant drug therapy
124398655 12439865 3 Liver transplant
124398655 12439865 4 Immunosuppressant drug therapy
124398655 12439865 5 Peritonitis bacterial
124398655 12439865 6 Peritonitis bacterial
124398655 12439865 8 Prophylaxis
124398655 12439865 9 Peritonitis bacterial
124398655 12439865 10 Prophylaxis
124398655 12439865 11 Prophylaxis
124398655 12439865 12 Product used for unknown indication
124398655 12439865 13 Product used for unknown indication
124398655 12439865 14 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
124398655 12439865 DE
124398655 12439865 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124398655 12439865 Abdominal compartment syndrome
124398655 12439865 Cholangitis
124398655 12439865 Drug resistance
124398655 12439865 Multiple organ dysfunction syndrome
124398655 12439865 Treatment failure
124398655 12439865 Trichosporon infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found